Volume 38, Issue 6 e15367
ORIGINAL ARTICLE

Prevalence of iron deficiency and anemia in pediatric heart transplant recipients

David M. Newland

Corresponding Author

David M. Newland

Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA

School of Pharmacy, University of Washington, Seattle, Washington, USA

Correspondence

David M. Newland, Department of Pharmacy, Seattle Children's Hospital, 4800 Sandpoint Way NE, Mailstop MB.5.420, Seattle, WA 98105, USA.

Email: [email protected]

Search for more papers by this author
Kathryn L. Spencer

Kathryn L. Spencer

Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA

Search for more papers by this author
Long D. Do

Long D. Do

Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA

Search for more papers by this author
Lisa R. Knorr

Lisa R. Knorr

Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA

School of Pharmacy, University of Washington, Seattle, Washington, USA

Search for more papers by this author
Michelle M. Palmer

Michelle M. Palmer

Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA

School of Pharmacy, University of Washington, Seattle, Washington, USA

Search for more papers by this author
Erin L. Albers

Erin L. Albers

Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA

School of Medicine, University of Washington, Seattle, Washington, USA

Search for more papers by this author
Joshua M. Friedland-Little

Joshua M. Friedland-Little

Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA

School of Medicine, University of Washington, Seattle, Washington, USA

Search for more papers by this author
Borah J. Hong

Borah J. Hong

Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA

School of Medicine, University of Washington, Seattle, Washington, USA

Search for more papers by this author
Mariska S. Kemna

Mariska S. Kemna

Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA

School of Medicine, University of Washington, Seattle, Washington, USA

Search for more papers by this author
Christina Hartje-Dunn

Christina Hartje-Dunn

Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA

School of Medicine, University of Washington, Seattle, Washington, USA

Search for more papers by this author
Dominique G. Mark

Dominique G. Mark

Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA

School of Pharmacy, University of Washington, Seattle, Washington, USA

Search for more papers by this author
Thomas L. Nemeth

Thomas L. Nemeth

Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA

School of Pharmacy, University of Washington, Seattle, Washington, USA

Search for more papers by this author
Sara Ravi-Johnson

Sara Ravi-Johnson

Clinical Nutrition, Seattle Children's Hospital, Seattle, Washington, USA

Search for more papers by this author
Yuk M. Law

Yuk M. Law

Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA

School of Medicine, University of Washington, Seattle, Washington, USA

Search for more papers by this author
First published: 29 May 2024

Abstract

Introduction

The prevalence of iron deficiency and anemia in the setting of modern-day maintenance immunosuppression in pediatric heart transplant (HTx) recipients is unclear. The primary aim was to determine the prevalence of iron deficiency (serum ferritin < 30 ng/mL ± transferrin saturation < 20%) and anemia per World Health Organization diagnostic criteria and associated risk factors.

Methods

Single-center, cross-sectional analysis of 200 consecutive pediatric HTx recipients (<21 years old) from 2005 to 2021. Data were collected at 1-year post-HTx at the time of annual protocol biopsy.

Results

Median age at transplant was 3 years (IQR .5–12.2). The median ferritin level was 32 ng/mL with 46% having ferritin < 30 ng/mL. Median transferrin saturation (TSAT) was 22% with 47% having TSAT < 20%. Median hemoglobin was 11 g/dL with 54% having anemia. Multivariable analysis revealed lower absolute lymphocyte count, TSAT < 20%, and estimated glomerular filtration rate <75 mL/min/1.73 m2 were independently associated with anemia. Ferritin < 30 ng/mL in isolation was not associated with anemia. Ferritin < 30 ng/mL may aid in detecting absolute iron deficiency while TSAT < 20% may be useful in identifying patients with functional iron deficiency ± anemia in pediatric HTx recipients.

Conclusion

Iron deficiency and anemia are highly prevalent in pediatric HTx recipients. Future studies are needed to assess the impact of iron deficiency, whether with or without anemia, on clinical outcomes in pediatric HTx recipients.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.